1. Xu, Z, Yang, J, Hu, J, et al. Primary aldosteronism in patients in China with recently detected hypertension. J Am Coll Cardiol 2020; 75: 1913–1922.
Google Scholar | Crossref | Medline2. Funder, JW, Carey, RM, Mantero, F, et al. The management of primary aldosteronism: case detection, diagnosis, and treatment: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 2016; 101: 1889–1916.
Google Scholar | Crossref | Medline3. Hannemann, A, Wallaschofski, H. Prevalence of primary aldosteronism in patient’s cohorts and in population-based studies – a review of the current literature. Horm Metab Res 2012; 44: 157–162.
Google Scholar | Crossref | Medline4. Ingelsson, E, Pencina, MJ, Tofler, GH, et al. Multimarker approach to evaluate the incidence of the metabolic syndrome and longitudinal changes in metabolic risk factors: the Framingham Offspring Study. Circulation 2007; 116: 984–992.
Google Scholar | Crossref | Medline5. Reincke, M, Meisinger, C, Holle, R, et al. Is primary aldosteronism associated with diabetes mellitus? Results of the German Conn’s Registry. Horm Metab Res 2010; 42: 435–439.
Google Scholar | Crossref | Medline6. Catena, C, Lapenna, R, Baroselli, S, et al. Insulin sensitivity in patients with primary aldosteronism: a follow-up study. J Clin Endocrinol Metab 2006; 91: 3457–3463.
Google Scholar | Crossref | Medline7. Blacher, J, Guerin, AP, Pannier, B, et al. Impact of aortic stiffness on survival in end-stage renal disease. Circulation 1999; 99: 2434–2439.
Google Scholar | Crossref | Medline8. Meaume, S, Benetos, A, Henry, OF, et al. Aortic pulse wave velocity predicts cardiovascular mortality in subjects >70 years of age. Arterioscler Thromb Vasc Biol 2001; 21: 2046–2050.
Google Scholar | Crossref | Medline9. Zieman, SJ, Melenovsky, V, Kass, DA. Mechanisms, pathophysiology, and therapy of arterial stiffness. Arterioscler Thromb Vasc Biol 2005; 25: 932–943.
Google Scholar | Crossref | Medline10. Moore, JE, Xu, C, Glagov, S, et al. Fluid wall shear stress measurements in a model of the human abdominal aorta: oscillatory behavior and relationship to atherosclerosis. Atherosclerosis 1994; 110: 225–240.
Google Scholar | Crossref | Medline11. Wilkinson, IB, Fuchs, SA, Jansen, IM, et al. Reproducibility of pulse wave velocity and augmentation index measured by pulse wave analysis. J Hypertens 1998; 16: 2079–2084.
Google Scholar | Crossref | Medline12. Mitchell, GF, Hwang, S-J, Vasan, RS, et al. Arterial stiffness and cardiovascular events: the Framingham Heart Study. Circulation 2010; 121: 505–511.
Google Scholar | Crossref | Medline13. Cameron, JD, Bulpitt, CJ, Pinto, ES, et al. The aging of elastic and muscular arteries: a comparison of diabetic and nondiabetic subjects. Diabetes Care 2003; 26: 2133–2138.
Google Scholar | Crossref | Medline14. Cruickshank, K, Riste, L, Anderson, SG, et al. Aortic pulse-wave velocity and its relationship to mortality in diabetes and glucose intolerance: an integrated index of vascular function? Circulation 2002; 106: 2085–2090.
Google Scholar | Crossref | Medline15. Neves, MF, Cunha, AR, Cunha, MR, et al. The role of renin-angiotensin-aldosterone system and its new components in arterial stiffness and vascular aging. High Blood Press Cardiovasc Prev 2018; 25: 137–145.
Google Scholar | Crossref | Medline16. Bernini, G, Galetta, F, Franzoni, F, et al. Arterial stiffness, intima-media thickness and carotid artery fibrosis in patients with primary aldosteronism. J Hypertens 2008; 26: 2399–2405.
Google Scholar | Crossref | Medline17. Strauch, B, Petrák, O, Wichterle, D, et al. Increased arterial wall stiffness in primary aldosteronism in comparison with essential hypertension. Am J Hypertens 2006; 19: 909–914.
Google Scholar | Crossref | Medline18. Tsai, CH, Pan, CT, Chang, YY, et al. Left ventricular remodeling and dysfunction in primary aldosteronism. J Hum Hypertens 2021; 35: 131–147.
Google Scholar | Crossref | Medline19. Wu, VC, Hu, YH, Er, LK, et al. Case detection and diagnosis of primary aldosteronism – The consensus of Taiwan Society of Aldosteronism. J Formos Med Assoc 2017; 116: 993–1005.
Google Scholar | Crossref | Medline20. Cosentino, F, Grant, PJ, Aboyans, V, et al. 2019 ESC guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD. Eur Heart J 2020; 41: 255–323.
Google Scholar | Crossref | Medline21. Lin, YH, Lin, LY, Chen, A, et al. Adrenalectomy improves increased carotid intima-media thickness and arterial stiffness in patients with aldosterone producing adenoma. Atherosclerosis 2012; 221: 154–159.
Google Scholar | Crossref | Medline22. Wang, J, Liu, L, Zhou, Y, et al. Increased fasting glucose and the prevalence of arterial stiffness: a cross-sectional study in Chinese adults. Neurol Res 2014; 36: 427–433.
Google Scholar | Crossref | Medline23. Pan, CT, Tsai, C-H, Chen, Z-W, et al. Atrial fibrillation in primary aldosteronism. Horm Metab Res 2020; 52: 357–365.
Google Scholar | Crossref | Medline24. Chen, ZW, Tsai, C-H, Pan, CT, et al. Endothelial dysfunction in primary aldosteronism. Int J Mol Sci 2019; 20: 5214.
Google Scholar | Crossref25. Hanslik, G, Wallaschofski, H, Dietz, A, et al. Increased prevalence of diabetes mellitus and the metabolic syndrome in patients with primary aldosteronism of the German Conn’s Registry. Eur J Endocrinol 2015; 173: 665–675.
Google Scholar | Crossref | Medline26. Colussi, G, Catena, C, Lapenna, R, et al. Insulin resistance and hyperinsulinemia are related to plasma aldosterone levels in hypertensive patients. Diabetes Care 2007; 30: 2349–2354.
Google Scholar | Crossref | Medline27. Mosso, LM, Carvajal, CA, Maiz, A, et al. A possible association between primary aldosteronism and a lower beta-cell function. J Hypertens 2007; 25: 2125–2130.
Google Scholar | Crossref | Medline28. Matrozova, J, Steichen, O, Amar, L, et al. Fasting plasma glucose and serum lipids in patients with primary aldosteronism: a controlled cross-sectional study. Hypertension 2009; 53: 605–610.
Google Scholar | Crossref | Medline29. Remde, H, Hanslik, G, Rayes, N, et al. Glucose metabolism in primary aldosteronism. Horm Metab Res 2015; 47: 987–993.
Google Scholar | Crossref | Medline30. Grundy, SM . Obesity, metabolic syndrome, and cardiovascular disease. J Clin Endocrinol Metab 2004; 89: 2595–2600.
Google Scholar | Crossref | Medline31. Fan, W . Epidemiology in diabetes mellitus and cardiovascular disease. Cardiovasc Endocrinol 2017; 6: 8–16.
Google Scholar | Crossref | Medline32. Beckman, JA, Creager, MA, Libby, P. Diabetes and atherosclerosis: epidemiology, pathophysiology, and management. JAMA 2002; 287: 2570–2581.
Google Scholar | Crossref | Medline33. Asmar, R, Benetos, A, Topuchain, J, et al. Assessment of arterial distensibility by automatic pulse wave velocity measurement. Validation and clinical application studies. Hypertension 1995; 26: 485–490.
Google Scholar | Crossref | Medline34. Dumor, K, Shoemaker-Moyle, M, Nistala, R, et al. Arterial stiffness in hypertension: an update. Curr Hypertens Rep 2018; 20: 72.
Google Scholar | Crossref | Medline35. Vlachopoulos, C, Aznaouridis, K, Terentes-Printzios, D, et al. Prediction of cardiovascular events and all-cause mortality with Brachial-ankle elasticity index: a systematic review and meta-analysis. Hypertension 2012; 60: 556–562.
Google Scholar | Crossref | Medline36. Strauch, B, Petrák, O, Zelinka, T, et al. Adrenalectomy improves arterial stiffness in primary aldosteronism. Am J Hypertens 2008; 21: 1086–1092.
Google Scholar | Crossref | Medline37. Liao, CW, Lin, L-Y, Hung, C-S, et al. Time course and factors predicting arterial stiffness reversal in patients with aldosterone-producing adenoma after adrenalectomy: prospective study of 102 patients. Sci Rep 2016; 6: 20862.
Google Scholar | Crossref | Medline38. Bender, SB, McGraw, AP, Jaffe, IZ, et al. Mineralocorticoid receptor-mediated vascular insulin resistance: an early contributor to diabetes-related vascular disease. Diabetes 2013; 62: 313–319.
Google Scholar | Crossref | Medline39. Hitomi, H, Kiyomoto, H, Nishiyama, A, et al. Aldosterone suppresses insulin signaling via the downregulation of insulin receptor substrate-1 in vascular smooth muscle cells. Hypertension 2007; 50: 750–755.
Google Scholar | Crossref | Medline40. Lacolley, P, Regnault, V, Laurent, S. Mechanisms of arterial stiffening: from mechanotransduction to epigenetics. Arterioscler Thromb Vasc Biol 2020; 40: 1055–1062.
Google Scholar | Crossref | Medline41. Death, AK, Fisher, EJ, Mcgrath, KC, et al. High glucose alters matrix metalloproteinase expression in two key vascular cells: potential impact on atherosclerosis in diabetes. Atherosclerosis 2003; 168: 263–269.
Google Scholar | Crossref | Medline42. Lavrentyev, EN, Estes, AM, Malik, KU. Mechanism of high glucose induced angiotensin II production in rat vascular smooth muscle cells. Circ Res 2007; 101: 455–464.
Google Scholar | Crossref | Medline43. Kolluru, GK, Bir, SC, Kevil, CG. Endothelial dysfunction and diabetes: effects on angiogenesis, vascular remodeling, and wound healing. Int J Vasc Med 2012; 2012: 918267.
Google Scholar | Medline44. Bornfeldt, KE, Tabas, I. Insulin resistance, hyperglycemia, and atherosclerosis. Cell Metab 2011; 14: 575–585.
Google Scholar | Crossref | Medline45. Brown, NJ . Contribution of aldosterone to cardiovascular and renal inflammation and fibrosis. Nat Rev Nephrol 2013; 9: 459–469.
Google Scholar | Crossref | Medline46. Stehouwer, CD, Henry, RM, Ferreira, I. Arterial stiffness in diabetes and the metabolic syndrome: a pathway to cardiovascular disease. Diabetologia 2008; 51: 527–539.
Google Scholar | Crossref | Medline47. Chen, Y, Huang, Y, Li, X, et al. Association of arterial stiffness with HbA1c in 1000 type 2 diabetic patients with or without hypertension. Endocrine 2009; 36: 262–267.
Google Scholar | Crossref | Medline